The lungs in systemic sclerosis (scleroderma): a review and new information.

[1]  E. Hurd,et al.  Scleroderma and scleroderma-like disorders. , 1986, Seminars in arthritis and rheumatism.

[2]  T. Medsger,et al.  Alpha1‐antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis , 1986 .

[3]  R. Silver,et al.  Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid. , 1986, Arthritis and rheumatism.

[4]  B. Wallaert,et al.  Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. , 1986, The American review of respiratory disease.

[5]  P. Manganelli,et al.  Bronchoalveolar lavage analysis of interstitial lung disease in CREST syndrome. , 1986, Clinical and Experimental Rheumatology.

[6]  T. Medsger,et al.  Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. , 1986, Arthritis and rheumatism.

[7]  T. Medsger,et al.  Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis. , 1986, The Journal of laboratory and clinical medicine.

[8]  Medsger Ta.  Systemic sclerosis and malignancy--are they related? , 1985 .

[9]  T. Medsger,et al.  Cancer and systemic sclerosis. An epidemiologic study. , 1985, Arthritis and rheumatism.

[10]  M. Hochberg,et al.  Incidence of lung cancer in systemic sclerosis. , 1985, The Journal of rheumatology.

[11]  M. Ramsden,et al.  Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features. , 1985, The Journal of rheumatology.

[12]  T. Medsger,et al.  The effect of D-penicillamine on pulmonary findings in systemic sclerosis. , 1985, Arthritis and rheumatism.

[13]  T. Medsger,et al.  Pulmonary involvement in systemic sclerosis (scleroderma). , 1985, Arthritis and rheumatism.

[14]  V. Ferrans,et al.  Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. , 1985, The American review of respiratory disease.

[15]  W. Oetgen,et al.  Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis. , 1985, The American journal of medicine.

[16]  J. Hill,et al.  Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis. , 1985, American heart journal.

[17]  William N. Kelley,et al.  Textbook of rheumatology , 1985 .

[18]  M. Hochberg,et al.  Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. , 1984, The American journal of medicine.

[19]  R. Silver,et al.  Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. , 1984, Arthritis and rheumatism.

[20]  O. Braun-falco,et al.  Lung involvement in scleroderma. , 1984, Chest.

[21]  M. Utell,et al.  Raynaud's phenomenon of the lung. , 1984, The American journal of medicine.

[22]  B. Jonson,et al.  Factors limiting exercise performance in progressive systemic sclerosis. , 1983, Seminars in arthritis and rheumatism.

[23]  R. Rogers,et al.  Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. , 1983, Chest.

[24]  R. Asherson,et al.  Vascular reactivity and pulmonary hypertension in systemic sclerosis. , 1983, Arthritis and rheumatism.

[25]  D. Furst,et al.  Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. , 1983, The American journal of medicine.

[26]  N. Pettigrew,et al.  Hypoventilatory respiratory failure in generalised scleroderma , 1983, British medical journal.

[27]  M. Hochberg,et al.  Serial pulmonary function in systemic sclerosis. , 1982, The American journal of medicine.

[28]  R. Wise,et al.  The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon. , 1982, Chest.

[29]  F. Mastaglia,et al.  Respiratory muscle function and ventilatory control. I in patients with motor neurone disease. II in patients with myotonic dystrophy. , 1982, The Quarterly journal of medicine.

[30]  D. Furst,et al.  Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis. , 1981, Arthritis and rheumatism.

[31]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[32]  Sutherland Jb,et al.  Xenon-133 ventilation and perfusion studies in bronchiectasis. , 1980 .

[33]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[34]  M. Bettmann,et al.  Rapid onset of lung involvement in progressive systemic sclerosis. , 1979, Chest.

[35]  D. Hughes,et al.  Serial pulmonary function tests in progressive systemic sclerosis. , 1979, Thorax.

[36]  S. Chopra,et al.  Small airways in progressive systemic sclerosis (PSS). , 1979, The American journal of medicine.

[37]  R. Crystal,et al.  Bronchoalveolar Lavage in Interstitial Lung Disease , 1978 .

[38]  J Dosman,et al.  The relations between structural changes in small airways and pulmonary-function tests. , 1978, The New England journal of medicine.

[39]  H. Paulus,et al.  Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. , 1978, Arthritis and rheumatism.

[40]  M. Guttadauria,et al.  Pulmonary function in scleroderma. , 1977, Arthritis and rheumatism.

[41]  J. Shaver,et al.  Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). , 1977, Annals of internal medicine.

[42]  W. Roberts,et al.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. , 1977, The Journal of clinical investigation.

[43]  W. Roberts,et al.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. , 1976, Annals of internal medicine.

[44]  M. Orringer,et al.  Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications. , 1976, The Annals of thoracic surgery.

[45]  N. Pride,et al.  Lung distensibility. The static pressure-volume curve of the lungs and its use in clinical assessment. , 1976, British journal of diseases of the chest.

[46]  M. H. Williams,et al.  Serial changes in scleroderma and idiopathic interstitial lung disease. , 1973, Archives of internal medicine.

[47]  R. Cherniack,et al.  Regional ventilation-perfusion and hypoxia in cryptogenic fibrosing alveolitis. , 1973, The American review of respiratory disease.

[48]  R. Cherniack,et al.  Normal standards for ventilatory function using an automated wedge spirometer. , 1972, The American review of respiratory disease.

[49]  V. Grassi,et al.  Respiratory function in the aged. , 1971, Bulletin de physio-pathologie respiratoire.

[50]  A. Masi,et al.  Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. , 1971, Annals of internal medicine.

[51]  A. Masi,et al.  Epidemiology of systemic sclerosis (scleroderma). , 1971, Annals of internal medicine.

[52]  S. Godfrey,et al.  Lung function and the response to exercise in systemic sclerosis , 1969, Thorax.

[53]  P. Macklem,et al.  Frequency dependence of compliance as a test for obstruction in the small airways. , 1969, The Journal of clinical investigation.

[54]  J. Fries,et al.  Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. , 1969, The American journal of medicine.

[55]  A. Weaver,et al.  Clinical InvestigationsPulmonary Scleroderma , 1968 .

[56]  J. Hogg,et al.  Site and nature of airway obstruction in chronic obstructive lung disease. , 1968, The New England journal of medicine.

[57]  L. Dabich,et al.  Pulmonary Manifestations of Progressive Systemic Sclerosis , 1968, The American journal of the medical sciences.

[58]  A. Weaver,et al.  The lung scleroderma. , 1967, Mayo Clinic proceedings.

[59]  A. Masi,et al.  Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore. , 1967, Annals of internal medicine.

[60]  H. Puro,et al.  Analysis of twenty-seven cases of progressive systemic sclerosis (including two with combined systemic lupus erythematosus) and a review of the literature. , 1966, Journal of chronic diseases.

[61]  R. Harper,et al.  Progressive systemic sclerosis. , 1965, The British journal of radiology.

[62]  M. B. Divertie.  LUNG INVOLVEMENT IN THE CONNECTIVE TISSUE DISORDERS. , 1964, The Medical clinics of North America.

[63]  M. Sackner,et al.  THE PATHOPHYSIOLOGY OF SCLERODERMA INVOLVING THE HEART AND RESPIRATORY SYSTEM. , 1964, Annals of internal medicine.

[64]  G. Rodnan,et al.  AN EARLY PULMONARY PHYSIOLOGIC ABNORMALITY IN PROGRESSIVE SYSTEMIC SCLEROSIS (DIFFUSE SCLERODERMA). , 1964, The American journal of medicine.

[65]  J. Mead,et al.  IMPROVED TECHNIQUE FOR ESTIMATING PLEURAL PRESSURE FROM ESOPHAGEAL BALLOONS. , 1964, Journal of applied physiology.

[66]  B. Ritchie.  Pulmonary Function in Scleroderma , 1964, Thorax.

[67]  D. Hughes,et al.  Lung Function in Patients with Systemic Sclerosis , 1963, Thorax.

[68]  Rodnan Gp.  The natural history of progressive systemic sclerosis (diffuse scleroderma). , 1963 .

[69]  B. M. Lewis,et al.  Pulmonary function in scleroderma. Its relation to changes in the chest roentgenogram and in the skin of the thorax. , 1962, The American review of respiratory disease.

[70]  G. Rodnan,et al.  An historical account of the study of progressive systemic sclerosis (diffuse scleroderma). , 1962, Annals of internal medicine.

[71]  R. Winkelmann,et al.  Diffuse systemic scleroderma. A comparison with acrosclerosis. , 1962, Annals of internal medicine.

[72]  W. C. Ball,et al.  Regional pulmonary function studied with xenon 133. , 1962, The Journal of clinical investigation.

[73]  B. Gondos.  Roentgen manifestations in progressive systemic sclerosis (diffuse scleroderma). , 1960, The American journal of roentgenology, radium therapy, and nuclear medicine.

[74]  E. Hines,et al.  Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic Scleroderma: A Study of 271 Cases , 1960, Circulation.

[75]  Goldman Hi,et al.  Respiratory function tests; normal values at median altitudes and the prediction of normal results. , 1959 .

[76]  R. Richards,et al.  Cancer of the Lung in Progressive Systemic Sclerosis , 1958, Thorax.

[77]  R. Boucek,et al.  Use of relaxin in the treatment of scleroderma. , 1958, Journal of the American Medical Association.

[78]  D. Spain.  The association of terminal bronchiolar carcinoma with chronic interstitial inflammation and fibrosis of the lungs. , 1957, American review of tuberculosis.

[79]  E. B. Helwig,et al.  Progressive Systemic Sclerosis: Visceral Manifestations in Generalized Scleroderma , 1955 .

[80]  L. Opie.  The pulmonary manifestations of generalised scleroderma (progressive systemic sclerosis). , 1955, Diseases of the chest.

[81]  R. Klein,et al.  Treatment of scleroderma, sclerodactylia and calcinosis by chelation (EDTA). , 1955, The American journal of medicine.

[82]  D. Bates,et al.  The pulmonary diffusing capacity in normal subjects , 1955, The Journal of physiology.

[83]  M. Suzman,et al.  Corticotrophin and cortisone in the treatment of scleroderma. , 1955, The Quarterly journal of medicine.

[84]  Garland Lh,et al.  Roentgen findings in the collagen diseases. , 1954 .

[85]  P. Mahrer,et al.  Scleroderma: relation of pulmonary changes to esophageal disease. , 1954, Annals of internal medicine.

[86]  J. Zatuchni,et al.  Pulmonary fibrosis and terminal bronchiolar (“alveolar‐cell”) carcinoma in scleroderma , 1953, Cancer.

[87]  F. Goldner,et al.  Progressive systemic sclerosis (scleroderma). , 1953, The New England journal of medicine.

[88]  A. Curtis,et al.  USE OF PARAAMINOBENZOIC ACID IN DERMATOMYOSITIS AND SCLERODERMA: Report of Six Cases , 1950 .

[89]  J. Hollander.  ARTHRITIS AND ALLIED CONDITIONS , 1949 .

[90]  N. Zamcheck,et al.  Lung Volume and Pulmonary Dynamics in Raynaud's Disease. Effect of Exposure to Cold , 1941 .